Loading...

Loading...

Global Demand for Better Pediatric Treatments Grows
By MBN Staff - Mon, 11/24/2025 - 12:20
WHO’s GAP-f outlines new steps to expand access to age-appropriate medicines as global demand for pediatric treatments grows.
https://mexicobusiness.news/tag/pharmaceutical-innovation
More Health
Lilly Expands Access to Obesity Medicines Through US Agreement
By MBN Staff - Mon, 11/10/2025 - 11:12
Lilly partners with the US government to expand access to obesity drugs, reinforcing its long-term commitment to healthcare affordability.
Transforming Pharma Services: Competing on Innovation, Not Price
By Aura Moreno - Fri, 11/07/2025 - 12:32
By fostering integrated ecosystems and research, it is possible to accelerate market entry and drive growth, Helix Health’s Andrés Valencia.
Neuraxpharm Expands Multiple Sclerosis Initiatives in Mexico
By Aura Moreno - Wed, 09/24/2025 - 13:42
Pharmaceutical company Neuraxpharm Group will showcase advances in the treatment of central nervous system (CNS) disorders at ECTRIMS 2025.
FDA Approves Wegovy for Adults with MASH, Liver Fibrosis
By Sofía Garduño - Mon, 08/18/2025 - 09:14
The US FDA approves Wegovy to treat adults with MASH and moderate to advanced liver fibrosis, excluding cirrhosis.
Dräger’s Atlan A350 Series Gains US DoD Security Certification
By MBN Staff - Wed, 08/13/2025 - 10:08
Dräger’s Atlan A350 anesthesia workstation series earns US DoD cybersecurity certification, securing patient data in operating rooms.
Novartis Reports Positive Phase III Results for Sjögren’s Drug
By MBN Staff - Wed, 08/13/2025 - 09:02
Novartis reports Phase III success for ianalumab, a potential first targeted treatment for Sjögren’s disease.
J&J Files for FDA Approval of Oral Psoriasis Drug Icotrokinra
By Sofía Garduño - Tue, 07/22/2025 - 08:17
J&J submits NDA for icotrokinra, an oral IL-23 blocker for plaque psoriasis, based on four Phase 3 trials showing strong efficacy and safety.
AMIIF Advances Mexico’s Healthcare Through Pharma Innovation
By Sofía Garduño - Fri, 07/11/2025 - 13:07
AMIIF’s Innovation Week highlights pharma’s role in driving innovation and collaboration to address health challenges and improve patient outcomes.
MariTide, Orforglipron Show Progress in Global Trials
By MBN Staff - Sat, 06/28/2025 - 09:32
New trial data shows promising results for two GLP-1 treatments for obesity and type 2 diabetes, with studies conducted in Mexico and other countries.